Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
|
Device | H.E.L.P. PLASMAT FUTURA APHERESIS SYSTEM |
Generic Name | Lipoprotein, low density, removal |
Applicant | B. Braun Avitum AG SCHWARZENBERGER WEG 73-79 MELSUNGEN D-342-3421 |
PMA Number | P940016 |
Supplement Number | S013 |
Date Received | 09/30/2009 |
Decision Date | 07/22/2010 |
Product Code |
MMY |
Advisory Committee |
Gastroenterology/Urology |
Clinical Trials | NCT00526058
|
Supplement Type | Normal 180 Day Track |
Supplement Reason | Change Design/Components/Specifications/Material |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement APPROVAL FOR DESIGN MODIFICATIONS TO THE PLASMAT SECURA SYSTEM INCLUDING THE USE OF THE PLASMAT FUTURA MACHINE WITH SOFTWARE VERSION 2.6.01, THE FUTURA KIT, AND INDIVIDUALLY PACKAGED COMPONENTS. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME H.E.L.P. PLASMAT FUTURA APHERESIS SYSTEM AND IS INDICATED FOR ACUTELY REMOVING LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) FROM THE PLASMA OF THE FOLLOWING HIGH-RISK PATIENT POPULATIONS FOR WHOM DIET HAS BEEN INEFFECTIVE AND MAXIMUM DRUG THERAPY HAS EITHER BEEN INEFFECTIVE OR NOT TOLERATED:GROUP A: FUNCTIONAL HYPOCHOLESTEROL-EMIC HOMOZYGOTES WITH LDL-C > 500 MG/DL; GROUP B: FUNCTIONAL HYPOCHOLESTEROL-EMIC HOMOZYGOTES WITH LDL-C > 300 MG/DL; AND GROUP C: FUNCTIONAL HYPOCHOLESTEROL-EMIC HOMOZYGOTES WITH LDL-C > 200 MG/DL AND DOCUMENTED CORONARY ARTERY DISEASE. |
|
|